Status:
NO_LONGER_AVAILABLE
Pulsed Inhaled Nitric Oxide for the Treatment of Patients With Mild or Moderate COVID-19
Lead Sponsor:
Bellerophon
Conditions:
Coronavirus Infection
COVID-19
Eligibility:
All Genders
18-95 years
Brief Summary
The search for novel therapies to address the ongoing coronavirus (COVID-19) pandemic is ongoing. No proven therapies have been identified to prevent progression of the virus. Preliminary data suggest...
Detailed Description
NO is a naturally produced molecule that is critical to the immune response to defend against pathogens and infections. In vitro studies have shown that NO inhibits the replication of severe acute res...
Eligibility Criteria
Inclusion
- Signed Informed Consent Form (and assent as appropriate) prior to the initiation of any study mandated procedures or assessments.
- At least 18 years old
- Patients with proven or high suspicion of SARS-CoV-2 infection and on supplemental oxygen ≤ 10 L/minute
- Suspected or proven pneumonia on chest imaging
- Female patients of childbearing potential must have a negative pre-treatment pregnancy test (serum or urine). All female patients should take adequate precaution to avoid pregnancy.
- Willing and able to comply with treatment schedule and study procedures.
Exclusion
- Participating in any other clinical trial of an experimental treatment for COVID-19
- Gas exchange and ventilation requiring the use of any continuous positive airway pressure (CPAP), or any system of Non Invasive Ventilation (NIV), with Positive End-Expiratory Pressure (PEEP) ≤ 10 cmH2O prior to initiation of iNO
- Pregnancy, or positive pregnancy test in a pre-dose examination
- Open tracheostomy
- Clinical contra-indication, as deemed by the attending physician
- Use of a nitric oxide donor agent such as nitroglycerin or drugs known to increase methemoglobin such as lidocaine, prilocaine, benzocaine or dapsone at screening
- Known history or clinical evidence of heart failure, left ventricular dysfunction (LVEF \< 40 %)
- Patients reporting hemoptysis
Key Trial Info
Start Date :
Trial Type :
EXPANDED_ACCESS
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04358588
Last Update
February 21 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.